Clinical Trials Directory

Trials / Completed

CompletedNCT04368338

Lung Ultrasound to Diagnose COVID-19

Use of Lung Ultrasound in Patients Suspected of COVID-19 Infection in the Emergency Room

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Covid-19 (English acronym meaning coronavirus disease 2019) is an emerging infectious disease caused by a strain of coronavirus called SARS-CoV-2. The current pandemic has resulted in a significant number of admissions in the emergency room (ER) due to suspicion of COVID-19 infection. Use of lung ultrasound is standard practice to diagnose acute respiratory failure in ER. Recently, typical lung ultrasonographic characteristics of COVID-19 disease has been described. During the COVID-19 pandemic, the use of this tool could be of interest in order to allow an early, simple and reliable triage in patients with suspected COVID-19 infection admitted in ER. In addition, the visualization of early signs in specific areas could be a predictive marker of the severity of the disease. The objective of this project will be to study the association between the signs on lung ultrasound and the result of RT-PCR in patients with suspected COVID-19 infection in the ER.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCOVID-19 RT-PCRPolymerase chain reaction tests after reverse transcription for the detection of viral Covid-19 RNA (RT-PCR)
PROCEDURElung ultrasoundlung ultrasound is standard practice to diagnose acute respiratory failure in Emergency room

Timeline

Start date
2020-04-28
Primary completion
2021-01-28
Completion
2021-07-20
First posted
2020-04-29
Last updated
2021-07-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04368338. Inclusion in this directory is not an endorsement.